Get started
Dr. Reddy's Laboratories Ltd. Sponsored ADRDr. Reddy's Laboratories Ltd. Sponsored ADRDr. Reddy's Laboratories Ltd. Sponsored ADR

Dr. Reddy's Laboratories Ltd. Sponsored ADR

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Forecast Seasonals

RDDA trade ideas

DRREDDY - LongGrandfather, Father & Son Strategy RSI above 60 for Grandfather (Monthly time-frame) & Father (Weekly time-frame) RSI taking support on 40 for Son (Daily time-frame) Support of Hammer on 20 March 2024 didn't break. (Entry) Hammer Confirmation (Weekly) Above 6211 (Proper SL) SL will be low of hammer (Weekly) below 6034 (Lower SL) If the SL is too much you can use the SL of BeltHold Candlestick on Daily 28 March -- 6078 (Profit Level 1) 6342 (Profit Level 2) 6450
NSE:DRREDDYLong
by meharsidhu
1
DRREDDY | Swing Trade📊 DETAILS Sector: Pharmaceuticals & Drugs Mkt Cap: 100,744 cr Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. TTM PE : 19.27 (Low PE) Sector PE : 52.24 Beta : 0.54 📚 INSIGHTS Strong Performer Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation 1.79% away from 52 week high Outperformer - Dr Reddys Laboratories up by 1.9% v/s NIFTY 50 up by 0.87% in last 1 month 📈 FINANCIALS Piotroski Score of 8/9 indicates Strong Financials Disclaimer: This analysis is for educational purposes only, and I'm not a SEBI registered analyst. If you found this analysis helpful, I encourage you to like and share it. Your observations and comments are also welcomed below. Your support, likes, follows, and comments motivate me to consistently share valuable insights with you. 🔍 More Analysis & Trade Setups 🔍 For more technical analysis and trade setups, make sure to follow me on TradingView: www.tradingview.com
NSE:DRREDDYLong
by Munish_Jain
Dr Reddy-A large cap investment multibagger!Dr Reddy has given a huge weekly breakout from Inverted head and shoulders pattern. This stock is a blind buy for investment considering the pharma rally expected for next few years. Add on dips is the best way to accumulate such investment stock. The company has one of the best fundamentals as of date. Stock is available at PE of 20 and PEG of 0.52. the return ratios are above 20%. This stock has to be part of your portfolio if you prefer investing in large cap stocks. I had seen such pattern in Tata motors when the stock was trading around 440 few months back and now stock has almost doubled from that price. We can expect similar move in this stock but at a slower rate.
NSE:DRREDDYLong
by chartistamey
DRREDDY bullish; above 6070 ? - Wednesday 31 Jan.The above information does not constitute investment/trading recommendation and it is purely for educational purpose. Please check the Strategy below... SWING Trading Strategy: Position is created, only upon stock closing above the entry price on day closing basis and is held on for 5-10 trading sessions for larger gains (5-10%) INTRADAY Trading Strategy: 1) Impulse upmove stage: The strong upmove (nearly upto 2% from breakoutprice) happens within five to 15 minutes. "High Risk Traders" buy in hope of another 2% upmove intraday. "High Risk Traders" patiently wait through the Pullback-Consolidation stage to realize profits. High risk/High reward set up as breakouts may fakeout (reversal)also 2) Pullback-Consolidation stage: After the above "Impulse upmove stage"; the price may then pull back and move sideways (between "Open" price and "High" of the above "Impulse upmove stage"). Safe traders with minimum risk profile wait for a breakout from the consolidation to enter at this stage to relize high profits in the final intraday final "Breakout continuation" stage 3) Breakout continuation: Stocks often in the third stage breaks up above the "High" of the first "Impulse upmove stage" and continue to go higher again. Both Safe Traders/High Risk Traders book profits at this stage This do not constitute, financial, investment, trading, or other types of advice or recommendation.
NSE:DRREDDYLong
by JJ_Breakouts
DRREDDY - Dr Reddy's Laboratories Ltd - Longterm - Bullish1. Annual Revenue rose 16.78%, in the last year to Rs 25,725 Crores. Its sector's average revenue growth for the last fiscal year was 8.64%. 2. Annual Net Profit rose 106.52% in the last year to Rs 4,507 Crores. Its sector's average net profit growth for the last fiscal year was 2.34%. 3. Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity. 4. Interest Coverage Ratio is 51.85, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT). 5. Price to Earning Ratio is 19.19, lower than its sector PE ratio of 43.
NSE:DRREDDYLong
by tnjarivoli